1. Home
  2. TVTX vs GHLD Comparison

TVTX vs GHLD Comparison

Compare TVTX & GHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • GHLD
  • Stock Information
  • Founded
  • TVTX 2008
  • GHLD 1960
  • Country
  • TVTX United States
  • GHLD United States
  • Employees
  • TVTX N/A
  • GHLD N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • GHLD Finance: Consumer Services
  • Sector
  • TVTX Health Care
  • GHLD Finance
  • Exchange
  • TVTX Nasdaq
  • GHLD Nasdaq
  • Market Cap
  • TVTX 1.5B
  • GHLD 1.2B
  • IPO Year
  • TVTX N/A
  • GHLD 2020
  • Fundamental
  • Price
  • TVTX $17.92
  • GHLD $19.88
  • Analyst Decision
  • TVTX Strong Buy
  • GHLD Hold
  • Analyst Count
  • TVTX 16
  • GHLD 6
  • Target Price
  • TVTX $33.40
  • GHLD $18.10
  • AVG Volume (30 Days)
  • TVTX 1.5M
  • GHLD 75.4K
  • Earning Date
  • TVTX 08-06-2025
  • GHLD 08-07-2025
  • Dividend Yield
  • TVTX N/A
  • GHLD 3.78%
  • EPS Growth
  • TVTX N/A
  • GHLD N/A
  • EPS
  • TVTX N/A
  • GHLD 0.42
  • Revenue
  • TVTX $333,865,000.00
  • GHLD $1,125,872,000.00
  • Revenue This Year
  • TVTX $71.61
  • GHLD $5.64
  • Revenue Next Year
  • TVTX $43.45
  • GHLD $26.37
  • P/E Ratio
  • TVTX N/A
  • GHLD $47.48
  • Revenue Growth
  • TVTX 87.94
  • GHLD 23.19
  • 52 Week Low
  • TVTX $8.46
  • GHLD $11.21
  • 52 Week High
  • TVTX $25.29
  • GHLD $23.57
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 59.60
  • GHLD 59.56
  • Support Level
  • TVTX $17.24
  • GHLD $19.80
  • Resistance Level
  • TVTX $19.08
  • GHLD $19.95
  • Average True Range (ATR)
  • TVTX 0.87
  • GHLD 0.41
  • MACD
  • TVTX 0.04
  • GHLD -0.09
  • Stochastic Oscillator
  • TVTX 66.67
  • GHLD 2.64

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About GHLD Guild Holdings Company

Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.

Share on Social Networks: